Cite
HARVARD Citation
Cantilena, S. et al. (2022). Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. Clinical and translational medicine. 12 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cantilena, S. et al. (2022). Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. Clinical and translational medicine. 12 (6), p. n/a. [Online].